bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2013: M A M F J
2012: D N O S A J J M

 
  Other news for:
Infertility
Pregnancy
Pregnancy Complications
 Resources from HONselect
Blood Clots During Pregnancy More Likely After IVF, Study Says
But the overall risk is still slight

By Steven Reinberg
HealthDay Reporter

TUESDAY, Jan. 15 (HealthDay News) -- Women who became pregnant through in vitro fertilization (IVF) may have an increased risk of developing blood clots and potentially fatal artery blockage, Swedish investigators suggest.

Although the risk remains small, the odds are especially high during the first trimester compared to women who become pregnant naturally, the researchers said.

Blood clots -- called venous thromboembolism -- can develop in the leg veins and break free, traveling to the lungs and blocking a main artery. This condition, called pulmonary embolism, can cause difficulty breathing and even death.

"There is an increased incidence of pulmonary embolism and venous thrombosis among women pregnant after IVF," said lead researcher Dr. Peter Henriksson, a professor of internal medicine at the Karolinska Institute in Stockholm. "Embolism is the leading cause of maternal mortality during pregnancy. The diagnosis can be elusive, so physicians should be aware of this risk to facilitate the diagnosis."

The risk of clotting during pregnancy isn't confined to women who undergo IVF, another experts said.

"Any pregnancy carries a risk of clotting," said Dr. Avner Hershlag, chief of the Center for Human Reproduction at North Shore University Hospital in Manhasset, N.Y.

This is because hormones, particularly estrogen, increase during pregnancy, Hershlag said. "This changes what we call the clotting cascade," he said. "There are many factors in blood clotting that can be affected by hormones -- especially estrogen."

In addition, the enlarging uterus puts pressure on pelvic blood vessels, which can lead to clotting. Some women are advised to limit their movement to reduce the risk of clotting, Hershlag noted.

Although it's unclear why women who undergo IVF have a greater risk of clotting, Hershlag speculates that it could be due to fertility treatments that increase estrogen even beyond levels normally associated with pregnancy.

The genetics of women who need IVF to conceive may also be a factor, he added.

Worldwide, about 10 percent of couples experience infertility, according to background information in the study. In IVF, eggs are removed from a woman's body, fertilized by the man's sperm and returned to her body. Since the world's first "test tube" baby was born in 1978, about 5 million births have occurred after IVF.

For the study, published Jan. 15 in the online edition of the journal BMJ, researchers compared data on more than 23,000 women who became pregnant after IVF with nearly 117,000 women who conceived without assisted technology.

The researchers found that for women who had undergone IVF, the risk for a blood clot was 4.2 in 1,000 women. For the women with normal pregnancies, the risk was 2.5 in 1,000. Moreover, the risk was highest during the first trimester.

Pulmonary embolism occurred in 19 women who had IVF (8.1 out of 10,000) compared with 70 women who conceived normally (6.0 out of 10,000), the study found.

The researchers caution that the absolute risk of a pulmonary embolism among women who had IVF was still slight -- two to three additional cases in 10,000 women.

"We don't want patients to get scared," Hershlag said. "Even with IVF, getting a blood clot is still pretty rare."

Also, most blood clots do not go to the lungs and can easily be treated and resolved, Hershlag said. Women at risk for clots can be treated with blood thinners that prevent clots, he said.

More information

For more information on IVF, visit the U.S. National Library of Medicine.

SOURCES: Peter Henriksson, M.D., Ph.D., profesor of internal medicine, Karolinska Institute, Stockholm, Sweden; Avner Hershlag, M.D., chief, Center for Human Reproduction, North Shore University Hospital, Manhasset, N.Y.; Jan. 15, 2013, BMJ, online

Copyright © 2013 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=672510

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Women
Blood
Risk
Research Personnel
Embolism
Pulmonary Embolism
Diagnosis
Hormones
Infertility
Lead
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact